Published 09/20/2024 12:30:00 a.m.

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Summary by News Medical

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

0 Articles

All

Left

Center

Right

News Medical

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

09/20/2024 12:30:00 a.m.·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated09/20/2024 1:12:04 a.m.Bias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

0 Articles

0 Articles

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics